Vanessa Pachón

1.9k total citations
19 papers, 242 citations indexed

About

Vanessa Pachón is a scholar working on Oncology, Epidemiology and Molecular Biology. According to data from OpenAlex, Vanessa Pachón has authored 19 papers receiving a total of 242 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 6 papers in Epidemiology and 5 papers in Molecular Biology. Recurrent topics in Vanessa Pachón's work include Colorectal Cancer Treatments and Studies (6 papers), Neuroendocrine Tumor Research Advances (5 papers) and Lung Cancer Research Studies (4 papers). Vanessa Pachón is often cited by papers focused on Colorectal Cancer Treatments and Studies (6 papers), Neuroendocrine Tumor Research Advances (5 papers) and Lung Cancer Research Studies (4 papers). Vanessa Pachón collaborates with scholars based in Spain, United States and Palestinian Territory. Vanessa Pachón's co-authors include Pilar García‐Alfonso, Xandra García‐González, Luis A. López‐Fernández, Luis Robles, María Sanjurjo‐Sáez, Federico Longo, María I. García, Virginia Martínez, Alfredo Carrato and Cristina Grávalos and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Vanessa Pachón

17 papers receiving 240 citations

Peers

Countries citing papers authored by Vanessa Pachón

Since Specialization

Citations

This map shows the geographic impact of Vanessa Pachón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanessa Pachón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanessa Pachón more than expected).

Fields of papers citing papers by Vanessa Pachón

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vanessa Pachón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanessa Pachón. The network helps show where Vanessa Pachón may publish in the future.

Co-authorship network of co-authors of Vanessa Pachón

This figure shows the co-authorship network connecting the top 25 collaborators of Vanessa Pachón. A scholar is included among the top collaborators of Vanessa Pachón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vanessa Pachón. Vanessa Pachón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Cancer-associated venous thromboembolism and its impact on survival in the ONCOTHROMB12-01 cohort study 2025 ·IJC Heart & Vasculature ·(unknown), (unknown), Carme Font, Vanessa Pachón, (unknown), Virginia Martínez-Marín, Mercedes Salgado Fernández, (unknown), Julia Calzas, (unknown), (unknown), Oriol Pujol, José Manuel Soria, (unknown)	1
2	Single nucleotide polymorphisms: impact on susceptibility to chemotherapy in patients with colorectal cancer 2024 ·Future Science OA ·María Ángeles Vaz Salgado, Víctor Albarrán, Javier Pozas, (unknown), Vanessa Pachón, Federico Longo, Mercedes Rodríguez, (unknown), Julie Earl	0
3	New DPYD variants causing DPD deficiency in patients treated with fluoropyrimidine 2020 ·Cancer Chemotherapy and Pharmacology ·Xandra García‐González, (unknown), (unknown), Fabienne Thomas, Pilar García‐Alfonso, Luis Robles, Vanessa Pachón, (unknown), (unknown), María Sanjurjo‐Sáez, Luis A. López‐Fernández	15
4	A comprehensive analysis of candidate genes in familial pancreatic cancer families reveals a high frequency of potentially pathogenic germline variants 2020 ·EBioMedicine ·Julie Earl, (unknown), Jessica Encinas, (unknown), María E. Castillo, Vanessa Pachón, (unknown), Mercedes Rodríguez-Garrote, Silvia González-Martínez, Teresa Ramón y Cajal, (unknown), (unknown), (unknown), (unknown), David García‐Seisdedos, Gloria Muñoz, (unknown), Mirari Márquez, Núria Malats, Alfredo Carrato	33
5	Direct oral anticoagulants for the treatment and prevention of venous thromboembolism in patients with cancer: current evidence 2020 ·Clinical & Translational Oncology ·Ignacio Escobar, Elena Brozos-Vázquez, David Gutiérrez Abad, Virginia Martínez-Marín, Vanessa Pachón, Andrés J. Muñoz Martín	3
6	Does Rapid Drug Desensitization to Chemotherapy Affect Survival Outcomes? 2019 ·Journal of Investigational Allergology and Clinical Immunology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Vanessa Pachón, (unknown), Ricardo Madrigal‐Burgaleta, Emilio Álvarez-Cuesta	27
7	Clinical utility of ABCB1 genotyping for preventing toxicity in treatment with irinotecan 2018 ·Pharmacological Research ·(unknown), Xandra García‐González, María I. García, (unknown), Pilar García‐Alfonso, Luis Robles, Cristina Grávalos, Vanessa Pachón, Federico Longo, Virginia Martínez, María Sanjurjo‐Sáez, Luis A. López‐Fernández	19
8	Cancer-Associated Thrombosis: Beyond Clinical Practice Guidelines—A Multidisciplinary (SEMI–SEOM–SETH) Expert Consensus 2018 ·SHILAP Revista de lepidopterología ·Vanessa Pachón, Javier Trujillo‐Santos, Pere Pascual i Domènech, Enrique Gallardo, Carme Font, José Ramón González‐Porras, Pedro Pérez‐Segura, Ana Maestre, José Mateo, Andrés J. Muñoz Martín, (unknown), Ramón Lecumberri	17
9	Identification of new SNPs associated with severe toxicity to capecitabine 2017 ·Pharmacological Research ·Marta Pellicer, Xandra García‐González, María I. García, Luis Robles, Cristina Grávalos, Pilar García‐Alfonso, Vanessa Pachón, Federico Longo, Virginia Martínez, (unknown), Irene Iglesias Peinado, María Sanjurjo‐Sáez, Luis A. López‐Fernández	39
10	Use of Exome Sequencing to Determine the Full Profile of Genetic Variants in the Fluoropyrimidine Pathway in Colorectal Cancer Patients Affected by Severe Toxicity 2017 ·Pharmacogenomics ·Marta Pellicer, Xandra García‐González, María I. García, (unknown), Pilar García‐Alfonso, Luis Robles, Cristina Grávalos, Daniel Rueda, Joaquín Martínez‐López, Vanessa Pachón, Federico Longo, Virginia Martínez, Irene Iglesias Peinado, (unknown), María Sanjurjo‐Sáez, Luis A. López‐Fernández	11
11	Incidence of incidental and symptomatic venous thromboembolism (VTE) and Khorana’s score in ambulatory pancreatic cancer patients receiving chemotherapy. 2014 ·Journal of Clinical Oncology ·Andrés J. Muñoz Martín, (unknown), Luisa Sánchez‐Lorenzo, Eva Martínez de Castro, Pascuala Garcı́a-Martı́nez, Vanessa Pachón, Joaquina Martínez-Galán, (unknown), (unknown), Sara Ramírez, (unknown), (unknown), Paula Jiménez‐Fonseca	1
12	Prognostic Factors and Long-Term Outcome of Pancreatic Neuroendocrine Neoplasms: Ki-67 Index Shows a Greater Impact on Survival than Disease Stage. The Large Experience of the Spanish National Tumor Registry (RGETNE) 2013 ·Neuroendocrinology ·Elena Martín‐Pérez, Jaume Capdevila, Daniel Castellano, Paula Jiménez‐Fonseca, Ramón Salazar, (unknown), Vicente Alonso-Orduña, Purificación Martínez del Prado, (unknown), José A. Díaz-Pérez, Toni Monleón-Getino, Mónica Marazuela, Vanessa Pachón, (unknown), Isabel Sevilla, Ángel Castaño, Rocio García‐Carbonero	50
13	Pazonet: A Phase II Trial of Pazopanib as a Sequencing Treatment in Progressive Metastatic Neuroendocrine Tumors (NETS) Patients (PTS), On Behalf of The Spanish Task Force for Nets (GETNE) 2012 ·Annals of Oncology ·Enrique Grande, Daniel Castellano, Rocio García‐Carbonero, Àlex Teulé, Ignacio Durán, Josep Fuster, Isabel Sevilla, P. Escudero, Javier Sastre, Oriol Casanovas, Luís Ortega, Julie Earl, Juan J. Díez, Guillermo de Velasco, Federico Longo, Alejandro Navarro, Vanessa Pachón, Alfredo Carrato, Ramón Salazar, Jaume Capdevila	3
14	Response by Choi criteria to sunitinib plus octreotide LAR in a functional heavily pretreated advanced pancreatic neuroendocrine tumor 2011 ·Anti-Cancer Drugs ·Enrique Grande, Juan J. Díez, Vanessa Pachón, María Ángeles Vaz Salgado, Federico Longo, Carmen Guillén‐Ponce, (unknown), Alfredo Carrato	7
15	Complete response to sunitinib in a patient with relapsed irresectable renal cell carcinoma 2011 ·Anti-Cancer Drugs ·María Ángeles Vaz Salgado, Vanessa Pachón, Enrique Grande, (unknown), Alfredo Carrato	3
16	Advances in the therapy of gastroenteropancreatic-neuroendocrine tumours (GEP-NETs) 2010 ·Clinical & Translational Oncology ·Enrique Grande, Juan J. Díez, Vanessa Pachón, Alfredo Carrato	5
17	A phase II trial of a biweekly schedule of capecitabine (X) plus irinotecan (I) as first-line treatment in patients (pts) with metastatic colorectal cancer (MCRC) 2005 ·Journal of Clinical Oncology ·Pilar García‐Alfonso, G. Pérez-Manga, M. Carmen González, (unknown), Encarnación González‐Flores, (unknown), Matias Molina, Vanessa Pachón, L. Iglesias, (unknown)	1
18	Gemcitabine plus continuous infusion of 5-FU for heavily pretreated advanced colorectal cancer patients. Phase I/II study 2005 ·Journal of Clinical Oncology ·Vanessa Pachón, Pilar García‐Alfonso, L. Iglesias, (unknown), (unknown), (unknown), Víctor Díaz, G. Pérez-Manga	7
19	P115 Pleural effusion as the only manifestation of a non-Hodgkin lymphoma 2003 ·European Journal of Internal Medicine ·(unknown), Pablo Ryan, Victoriano Pardo, Vanessa Pachón, Blanca Pinilla, (unknown)	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact